Dietary Supplements; Center for Food Safety and Applied Nutrition; Public Meetings

Короткий зміст

The Food and Drug Administration (FDA) is announcing two public meetings to solicit comments that will assist the Center for Food Safety and Applied Nutrition (CFSAN) to understand the economic impact that any proposal to establish current good manufacturing practices (CGMP) regulations for dietary supplements may have on small businesses in the dietary supplement industry. These meetings are intended to give interested persons, including small businesses, an opportunity to comment on the economic impact that such a proposal may have on small businesses.